The amino-terminal domain guides subfamily-specific assembly of ionotropic glutam
氨基末端结构域指导离子型谷氨酸的亚家族特异性组装
基本信息
- 批准号:8475617
- 负责人:
- 金额:$ 28.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisBiochemicalBrainCationsCellsCellular biologyCholinergic ReceptorsCognitive deficitsCrystallizationDimerizationElectrophysiology (science)ElementsEnsureEpilepsyExtracellular DomainFutureGABA ReceptorGated Ion ChannelGatekeepingGluR2 subunit AMPA receptorGlutamate ReceptorGoalsHandHomodimerizationHumanInsectaIon ChannelIsoxazolesKainic Acid ReceptorsKineticsKnowledgeLearningLengthLigand Binding DomainLigandsLinkLong-Term PotentiationManualsMediatingMemoryMental disordersMethodsModelingMolecularMood DisordersNational Institute of Child Health and Human DevelopmentNatureNeuraxisNeurodegenerative DisordersNicotinic ReceptorsPhysiologicalPotassium ChannelProcessPropertyPropionic AcidsProtein EngineeringRecombinantsRegulationResolutionRoleSchizophreniaSequence AnalysisSite-Directed MutagenesisStructureSurfaceSynaptic plasticityTestingTherapeutic InterventionUltracentrifugationVoltage-Gated Potassium ChannelWorkXenopus oocytebasecyclic-nucleotide gated ion channelsdesensitizationdimerextracellularhigh throughput screeninginsightkainatemutantnervous system disorderneurotransmissionpolypeptidepreventpublic health relevancereceptorreceptor functionresearch studystoichiometrystructural biology
项目摘要
DESCRIPTION (provided by applicant): Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that form transmembrane, cation- permeable channels. The (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazole) propionic acid (AMPA) subtype of iGluRs (AMPAR) is essential for the fast excitatory neurotransmission in the central nervous system (CNS). Malfunction of AMPARs has been implicated in several neurodegenerative diseases such as Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS), as well as other neurological diseases such as cognitive deficits, epilepsy, schizophrenia, and mood disorders. For AMPARs as well as other iGluR subfamilies, active channels are tetramers exclusively formed by assembly of subunits within the same subfamily, a molecular process principally controlled by the extracellular amino-terminal domain (ATD). This phenomenon serves to control the permeation and kinetic properties of iGluR ion channels and is thus critical for maintaining normal physiological function of iGluRs. The goals of this proposal are to understand the molecular mechanisms by which the ATD guides subfamily-specific iGluR assembly. The specific aims are: (1) we will determine the crystal structures of the ATD of AMPARs; (2) we will characterize the role of the ATD in functional assembly of homomeric and heteromeric AMPAR channels; and (3) we will characterize the underlying mechanism by which ATDs guide subfamily-specific dimer-dimer association of iGluRs. The proposed study should provide a better understanding of the molecular principles governing iGluR assembly and function which could ultimately lay groundwork for future therapeutic interventions. Furthermore, molecular mechanisms governing iGluR assembly could be applicable for studying other multimeric ion channels/receptors, such as potassium channels, cyclic nucleotide-gated channels, nicotinic acetylcholine receptors, GABA receptors and others. Aberrant structure or function of these receptors/channels has been linked to many human neurological and psychiatric diseases.
描述(由申请人提供):离子型谷氨酸受体(iGluR)是配体门控离子通道,可形成跨膜阳离子渗透通道。iGluRs(AMPAR)的(S)-2-氨基-3-(3-羟基-5-甲基-4-异恶唑)丙酸(AMPA)亚型对于中枢神经系统(CNS)中的快速兴奋性神经传递是必需的。AMPAR的功能障碍涉及几种神经退行性疾病,如阿尔茨海默病(AD)和肌萎缩侧索硬化症(ALS),以及其他神经系统疾病,如认知缺陷、癫痫、精神分裂症和情绪障碍。对于AMPAR以及其他iGluR亚家族,活性通道是仅通过相同亚家族内的亚基组装形成的四聚体,这是主要由胞外氨基末端结构域(ATD)控制的分子过程。这种现象用于控制iGluR离子通道的渗透和动力学性质,因此对于维持iGluR的正常生理功能至关重要。该提案的目标是了解ATD引导亚家族特异性iGluR组装的分子机制。具体目标是:(1)我们将确定AMPAR的ATD的晶体结构;(2)我们将表征ATD在同聚和异聚AMPAR通道的功能组装中的作用;(3)我们将表征ATD引导iGluR的亚家族特异性二聚体-二聚体缔合的潜在机制。这项拟议的研究应该提供一个更好的理解的分子原则,管理iGluR的组装和功能,最终奠定了基础,为未来的治疗干预。此外,控制iGluR组装的分子机制可适用于研究其他多聚体离子通道/受体,如钾通道、环核苷酸门控通道、烟碱乙酰胆碱受体、GABA受体等。这些受体/通道的异常结构或功能与许多人类神经和精神疾病有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rongsheng Jin其他文献
Rongsheng Jin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rongsheng Jin', 18)}}的其他基金
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 28.68万 - 项目类别:
Structural basis for recognition of SV2 by type E botulinum neurotoxin
E型肉毒杆菌神经毒素识别SV2的结构基础
- 批准号:
10281936 - 财政年份:2021
- 资助金额:
$ 28.68万 - 项目类别:
Developing broad-spectrum therapeutics against C. difficile toxins
开发针对艰难梭菌毒素的广谱疗法
- 批准号:
10181652 - 财政年份:2021
- 资助金额:
$ 28.68万 - 项目类别:
Structural basis for recognition of SV2 by type E botulinum neurotoxin
E型肉毒杆菌神经毒素识别SV2的结构基础
- 批准号:
10448471 - 财政年份:2021
- 资助金额:
$ 28.68万 - 项目类别:
Developing broad-spectrum therapeutics against C. difficile toxins
开发针对艰难梭菌毒素的广谱疗法
- 批准号:
10548826 - 财政年份:2021
- 资助金额:
$ 28.68万 - 项目类别:
Developing broad-spectrum therapeutics against C. difficile toxins
开发针对艰难梭菌毒素的广谱疗法
- 批准号:
10348784 - 财政年份:2021
- 资助金额:
$ 28.68万 - 项目类别:
Structural basis of Rho glucosylation by Clostridium difficile toxins
艰难梭菌毒素 Rho 糖基化的结构基础
- 批准号:
10308686 - 财政年份:2020
- 资助金额:
$ 28.68万 - 项目类别:
Molecular mechanisms of botulinum neurotoxin neutralization
肉毒杆菌神经毒素中和的分子机制
- 批准号:
9160875 - 财政年份:2016
- 资助金额:
$ 28.68万 - 项目类别:
Molecular mechanisms of botulinum neurotoxin neutralization
肉毒杆菌神经毒素中和的分子机制
- 批准号:
9918242 - 财政年份:2016
- 资助金额:
$ 28.68万 - 项目类别:
Structural mechanism for recognition of host receptor by botulinum neurotoxin A
A型肉毒杆菌神经毒素识别宿主受体的结构机制
- 批准号:
9238660 - 财政年份:2016
- 资助金额:
$ 28.68万 - 项目类别: